The global home sleep apnea testing market is on a trajectory of steady expansion, with sales projected to grow from an estimated USD 712.3 million in 2025 to USD 966.1 million by 2035. The market is ...

Radnor, Pennsylvania-based Mineralys is a clinical-stage biopharmaceutical company developing treatments for hypertension, ...

Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid ...

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., ...

Obstructive sleep apnea may increase the risk for Parkinson’s disease, but early intervention with continuous positive airway ...

Q: Should I be worried about Obstructive Sleep Apnea? Obstructive Sleep Apnea is estimated to affect 25 million Americans or ...

Preliminary screening for OSA in children who are awake, performed via an EEG, may help identify whether oxygen desaturation occurs at night.

For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is ...

Pulmonary hypertension is linked to an increased risk for sleep apnea and structural brain changes at the genetic level, a ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

The many reasons a person may sleepwalk include genetics, sleep deprivation, stress, migraines, fever, breathing disorders, ...

Call Scheduled for Monday, March 31, 2025 at 5:00 pm ETLITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device ...